264 related articles for article (PubMed ID: 31747618)
1. Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use.
Parashar D; Rajendran V; Shukla R; Sistla R
Eur J Pharm Sci; 2020 Jan; 142():105159. PubMed ID: 31747618
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional pH-Sensitive Amino Lipids for siRNA Delivery.
Gujrati M; Vaidya A; Lu ZR
Bioconjug Chem; 2016 Jan; 27(1):19-35. PubMed ID: 26629982
[TBL] [Abstract][Full Text] [Related]
3. Lipid nanoparticles for short interfering RNA delivery.
Leung AK; Tam YY; Cullis PR
Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
Sato Y; Matsui H; Sato R; Harashima H
J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
[TBL] [Abstract][Full Text] [Related]
5. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
Varshosaz J; Taymouri S
Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
[TBL] [Abstract][Full Text] [Related]
6. Glycerol monooleate-based nanocarriers for siRNA delivery in vitro.
Zhen G; Hinton TM; Muir BW; Shi S; Tizard M; McLean KM; Hartley PG; Gunatillake P
Mol Pharm; 2012 Sep; 9(9):2450-7. PubMed ID: 22794355
[TBL] [Abstract][Full Text] [Related]
7. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable lipid nanoparticles induce a prolonged RNA interference-mediated protein knockdown and show rapid hepatic clearance in mice and nonhuman primates.
Suzuki Y; Hyodo K; Suzuki T; Tanaka Y; Kikuchi H; Ishihara H
Int J Pharm; 2017 Mar; 519(1-2):34-43. PubMed ID: 28089936
[TBL] [Abstract][Full Text] [Related]
9. Lipid and Polymer-Based Nanoparticle siRNA Delivery Systems for Cancer Therapy.
Mainini F; Eccles MR
Molecules; 2020 Jun; 25(11):. PubMed ID: 32532030
[TBL] [Abstract][Full Text] [Related]
10. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
11. Recent patents in siRNA delivery employing nanoparticles as delivery vectors.
Nimesh S
Recent Pat DNA Gene Seq; 2012 Aug; 6(2):91-7. PubMed ID: 22670609
[TBL] [Abstract][Full Text] [Related]
12. Lipid-based nanoparticles in the systemic delivery of siRNA.
Lin Q; Chen J; Zhang Z; Zheng G
Nanomedicine (Lond); 2014 Jan; 9(1):105-20. PubMed ID: 24354813
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Delivery of siRNA to Retinal Ganglion Cells by Intravitreal Lipid Nanoparticles of Positive Charge.
Huang X; Chau Y
Mol Pharm; 2021 Jan; 18(1):377-385. PubMed ID: 33295773
[TBL] [Abstract][Full Text] [Related]
14. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo.
Jayaraman M; Ansell SM; Mui BL; Tam YK; Chen J; Du X; Butler D; Eltepu L; Matsuda S; Narayanannair JK; Rajeev KG; Hafez IM; Akinc A; Maier MA; Tracy MA; Cullis PR; Madden TD; Manoharan M; Hope MJ
Angew Chem Int Ed Engl; 2012 Aug; 51(34):8529-33. PubMed ID: 22782619
[TBL] [Abstract][Full Text] [Related]
15. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
[TBL] [Abstract][Full Text] [Related]
16. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
17. Targeted siRNA Delivery Using Lipid Nanoparticles.
Jorge A; Pais A; Vitorino C
Methods Mol Biol; 2020; 2059():259-283. PubMed ID: 31435927
[TBL] [Abstract][Full Text] [Related]
18. A review of nanocarriers for the delivery of small interfering RNA.
Kesharwani P; Gajbhiye V; Jain NK
Biomaterials; 2012 Oct; 33(29):7138-50. PubMed ID: 22796160
[TBL] [Abstract][Full Text] [Related]
19. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
20. siRNA nanotherapeutics: a Trojan horse approach against HIV.
Mishra V; Kesharwani P; Jain NK
Drug Discov Today; 2014 Dec; 19(12):1913-20. PubMed ID: 25281591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]